Judith Anne Shizuru - 24 Sep 2021 Form 3 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
24 Sep 2021
Net transactions value
$0
Form type
3
Filing time
01 Oct 2021, 16:10:45 UTC
Next filing
23 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JSPR Voting Common Stock 1,129,512 24 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JSPR Stock Option (right to buy) 24 Sep 2021 Common Stock 146,170 $0.7100 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 305,909 shares of restricted stock that are subject to vesting, of which 1/26th shall vest on October 20, 2021 and each month thereafter through and including November 20, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney